Ed Zhang

Ed Zhang's work experience includes:

- Co-founder and CEO of Overland Pharmaceuticals since January 2022.

- Interim CEO of Overland Pharmaceuticals from May 2021 to January 2022.

- Co-Founder, COO & CBO of Overland Pharmaceuticals from February 2020 to May 2021.

- Venture Partner, HH Bioventure at Hillhouse Capital Management since January 2020.

- Vice President of Corporate Development at Boston Pharmaceuticals from an unknown start date to January 2020.

- Senior Director of Business Development at ImmunoGen, Inc. from an unknown start date to an unknown end date.

- Senior Director, Global Business Development at Sanofi from an unknown start date to an unknown end date.

- Director, Commercial Operations and Strategic Development at Sanofi from an unknown start date to an unknown end date.

- Associate Director, Business Development at Sanofi from an unknown start date to an unknown end date.

- Business Development Manager at Sanofi from an unknown start date to an unknown end date.

- Senior Research Associate at Abbott Laboratories from an unknown start date to an unknown end date.

- Associate Scientist at Pharmacia from an unknown start date to an unknown end date.

Ed Zhang's education history includes earning an M.B.A. from Northwestern University - Kellogg School of Management, with coursework in finance, marketing, and biotechnology. Ed also holds an M.S. in organic chemistry from Binghamton University and a B.S. in chemistry from Nanjing University.